Diagnostic methods currently used for bladder cancer are cystoscopy and urine cytology.
Cystoscopy is an invasive tool and has low sensitivity for carcinoma in situ. Urine cytology is …

Since the discovery of circulating tumor cells in 1869, technological advances in the study of
biomarkers from liquid biopsy have made it possible to diagnose disease in a less invasive …

Alpha-synuclein is a presynaptic protein that forms abnormal cytoplasmic aggregates in
Lewy body disorders. Although nuclear alpha-synuclein localization has been described, its …

Background Urinary biomarkers for the diagnosis of bladder cancer represents an area of
considerable research which has been tested in both patients presenting with haematuria …

The cellular REDOX regulatory systems play a central role in maintaining REDOX
homeostasis that is crucial for cell integrity, survival, and proliferation. To date, a substantial …

For over 80 years, cystoscopy has remained the gold-standard for detecting tumours of the
urinary bladder. Since bladder tumours have a tendency to recur and progress, many …

The “gold standard” diagnostic procedure for bladder cancer is cystoscopy, a technique that
can be invasive, expensive, and a possible cause of urinary tract infection. Unlike …

Background Bladder cancer (BC) is among the most common cancers diagnosed in men in
the USA. The current gold standards for the diagnosis of BC are invasive or lack the …

The types of urothelial carcinoma (UC) include urothelial bladder cancer and upper tract
urothelial carcinoma. Current diagnostic techniques cannot meet the needs of patients …

Urinary extracellular vesicles (EVs) are an attractive source of bladder cancer biomarkers.
Here, a protein biomarker discovery study was performed on the protein content of small …